Erschienen in:
18.01.2020 | Review
Metabolomics, sleepiness, and sleep duration in sleep apnea
verfasst von:
Idiatou Diallo, Victoria M. Pak
Erschienen in:
Sleep and Breathing
|
Ausgabe 4/2020
Einloggen, um Zugang zu erhalten
Abstract
Purpose
Although the mechanism is unclear, daytime sleepiness, a common sequela of obstructive sleep apnea (OSA), has been found to be correlated with a adverse cardiovascular outcomes. Reviewing metabolomics mechanisms of sleep disturbances and cardiovascular disease may help to explain this correlation.
Methods
This review examines the current literature on the relationships between sleepiness, sleep duration, and metabolites in sleep apnea.
Results
Although there is a lack of comprehensive literature in this emerging area, existing studies point to a variety of metabolites in different pathways that are associated with sleepiness and sleep duration.
Conclusion
Advancing metabolomics research in sleep apnea will guide symptom research and provide alternate and novel opportunities for effective treatment for patients with OSA.